• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma 2015: Industry in Flux

Article

Pharma is still a 21st Century growth industry, but investment dynamics no longer favor organic growth. Check out our strategic outlook infographic.

 

Recent Videos
Related Content
Kirsten Jacobs

The Lifespan of Mature Drugs in 2025: Q&A with Kirsten Jacobs

Mike Hollan
December 18th 2024
Article

PharmaLex’s chief strategy officer discusses strategies to improve monetization for these drugs.

Seeking More Value, Less Cost

Seeking More Value, Less Cost

Michael Christel
December 17th 2024
Article

The biosimilars market in the US is on the rise, but barriers to greater adoption remain.

Dealmaking Dormant No More

Dealmaking Dormant No More

Mike Hollan
December 17th 2024
Article

Unleashed demand over the past year characterizes the M&A picture in pharma.

The Recipe for Relief: Overcoming Industry Pain Points

The Recipe for Relief: Overcoming Industry Pain Points

Diane Petrone
December 13th 2024
Article

Why investing in people and training can help drugmakers deal with six pressing challenges in particular in the year ahead.

Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Tanveer Ahmed Nasir;Pooja Jain
December 13th 2024
Article

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.